Background-Readmission is responsible for a large proportion of inpatient care costs in adult congenital heart disease.
H ospital readmission is an important metric used to evaluate care quality and efficiency. Readmissions are a popular target for quality improvement because they are costly and are thought to be largely preventable. [1] [2] [3] [4] Although this belief remains controversial, reduction of readmissions has been widely adopted as the standard for comparing relative quality of care and is now tied to federal reimbursement and penalties in the United States. 5 As with other heart diseases, rehospitalization is fundamentally important in the evaluation of care quality in adult congenital heart disease (ACHD). Chronic cardiac diseases such as ACHD are responsible for the majority of healthcare spending in the United States. 6 Recent data have shown that spending for inpatient care in patients with ACHD has been expanding rapidly. 7, 8 Given that the recently published suggestions for improving quality of ACHD care included improvements in cost effectiveness and efficiency as outcomes, research is needed to investigate strategies which may decrease readmission rate and improve these outcomes. 9, 10 In addition, Gurvitz et al 11 proposed quality of life as an important outcome to be tracked in providing optimal ACHD care. The strong link between quality of life and annual rate of hospitalization further supports the need for research in this area.
There is little information available on readmission rates in the ACHD population. In the present study, we sought to address this knowledge gap by investigating the frequency and character of unplanned readmissions among patients with ACHD in the United States. We also investigated potentially modifiable factors associated with increased risk for rehospitalization with the goal of identifying targets for improvement in care quality.
Methods
For this analysis, State Inpatient Databases (SID) were used which are part of the Healthcare Cost and Utilization Project. 12 We specifically used the SIDs for Arkansas (2008) (2009) (2010) , California (2003 California ( -2012 , Florida (2005 Florida ( -2012 , Hawaii (2006 Hawaii ( -2010 , Nebraska (2003 Nebraska ( -2011 , and New York (2005) (2006) (2007) (2008) (2009) (2010) (2011) (2012) . These SIDs were selected because they uniquely track hospitalizations in individual patients longitudinally, whereas data from other states track hospitalizations without tracking patients. The dates used were the most complete and up to date available at the time of analysis in April 2015. The primary outcome was readmission over a 12-month period for individual patients with ACHD in the states investigated. The present study was approved by the Institutional Review Board at Washington University School of Medicine.
As a first step, we identified patients in the databases with ACHD by selecting patients in the SIDs with an age of >18 years, and with a 3-digit International Classification of Diseases-Ninth Revision diagnosis code of 745, 746, or 747, the administrative codes that identify congenital cardiovascular anomalies. To this group of patients, we applied a validated hierarchical algorithm described by Broberg et al 13 to categorize patients based on anatomy. Any patients who failed to be classified according to this algorithm were excluded to increase the probability that all the patients included for analysis in fact had ACHD. Patients were classified at the time of index hospitalization. We then excluded patients with an index hospitalization within the first or last 12 months of the investigated period, so that we were certain that the index hospitalization was not a rehospitalization after one to which we were blind and that a full 12 months of follow-up post index was available for every patient, patients who died at the time of index admission, and patients with missing essential data. We finally excluded patients with a readmission that was categorized as elective based on HCUP categorization, given that these readmissions were most likely unpreventable. After applying the specified inclusion and exclusion criteria and trimming to remove outliers, the final sample consisted of 64 420 patients who had been hospitalized at least once during the study period.
We first investigated differences in the primary admitting diagnosis at the time of index admission between patients who were and those who were not readmitted within 12 months of an index admission. We conducted a χ 2 test comparing each of the 5 most common admitting diagnoses at index admission and readmission status. All tests were assigned a P value of ≤ 0.05 to determine significance. We next investigated the relative frequencies of various admitting diagnoses at the time of readmission in each anatomic group.
We thereafter compared the clinical and demographic characteristics of patients who were and were not readmitted within 12 months of an index admission using Student's 2-sample t test and χ 2 tests for continuous and categorical data, respectively. We used these analyses to facilitate identification of variables for construction of multivariable regression models. After considering the group of variables identified by this method, we further narrowed the list based on clinical experience and literature review. The final list of independent model variables derived in this manner varied depending on underlying cardiac anatomy.
Using these independent variables, we built a series of hierarchical multivariable logistic regression models with readmission within 12 months of index hospitalization as the dependent variable. These models treated site of hospitalization as a random effect to account for inherent differences between hospitals. A different model for each anatomic group was constructed. The sample size of each model varied because of the varying number of subjects in each diagnostic group. The odds ratios (ORs), 95% confidence intervals (CIs), and P values are reported from these models, and all significance tests were 2 sided with type I error set to 5%, ie, α=0.05. Using these models, we identified significant predictors of readmission for each anatomic group. As this was intended only as an exploratory analysis, the potential liability of multiple testing was not addressed.
Next, we built a similar series of hierarchical multivariable logistic regression models using the same sets of preidentified variables with readmission as the dependent variable, but this time converted all independent variables to dichotomous variables. Any variables that were categorical were converted to multiple dichotomous indicators using dummy variables. We did this so that we would be able to rank ORs for the independent variables in the models based on their ability to predict readmission. Because our patients were grouped by hospital, we again treated hospital as a random effect in the model. The ORs, 95% CIs, and P values were obtained, and ranks were derived. All significance tests were 2 sided with type I error set to 5%, ie, α=0.05. All analysis conducted in SAS version 9.4 (SAS Institute Inc., Cary, NC).
Results

Population
Our initial query of the SIDs resulted in 155 297 index admissions, and 619 720 readmissions among patients aged >18 years with a 3-digit International Classification of Diseases-Ninth Revision code of 745, 746, or 747. After excluding readmissions that fell outside the 365-day time window after an index admission, this left 112 113 readmission events that were linked to index admissions. After excluding patients who failed to be categorized according to the algorithm described by Broberg et al 13 (n=45 847), eliminating patients with index hospitalizations within the first or last 12 months (n=25 703), patients with planned readmissions (n=2827), patients for whom there was essential missing data (n=14 083), patients who died at the time of index admission (n=1603), and trimming data to eliminate patients with annual costs above the top 99% or below the lower 1% of the total cost distribution (n=859), this left a final sample size of n=64 420 index admissions as graphically depicted in Figure 1 .
Overall, 39% of patients experienced a readmission within 12 months of an index admission. Patients who were readmitted were slightly older (59.4±18.7 versus 55.3±18.3; P<0.001) and were slightly more likely to be women (52% versus 50%; P<0.001) than those who were not. Readmitted patients also had a longer length of stay at the time of index admission (8.3±20.0 versus 6.3±13.0; P<0.001) and were less likely to have had a major operation performed during their index admission (31% versus 46%; P<0.001). Patients with Eisenmenger syndrome or cyanosis, single ventricle, and conotruncal abnormality were more likely than not to be readmitted at least once in the 12 months after an index admission. All other lesions were more likely not to experience a readmission, with those having congenital aortic valve stenosis or a bicuspid aortic valve being the least likely to be readmitted. Complete demographic data are depicted in Table 1 .
Diagnosis at Index Admission
We first investigated which primary admitting diagnoses at the time of index admission were associated with a greater probability of readmission. We found differences among the
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top 5 most common reasons for admission in all anatomic groups. Congestive heart failure (CHF) was among the most common reasons for index admission regardless of group and was more common among patients with ACHD who would be readmitted than among those who would not. Cardiac arrhythmia was a more common admitting diagnosis among patients with ACHD who would be readmitted in all groups except single ventricle patients (in whom it was equally as common among nonreadmitted patients) and patients with AV septal defect, Ebstein's anomaly, and among those who failed to be characterized by the algorithm (in whom it was less common among readmitted patients). Cerebrovascular accident was more common among patients with ACHD who would be readmitted, attributable predominantly to patients with AV septal defect and shunts. We found that patients with ACHD who were not readmitted within 12 months were more likely to have a primary diagnosis of cardiac and congenital circulatory anomaly at the time of index admission. This finding was consistent across all anatomic groups. Nevertheless, there remained lesion-specific variability in primary diagnosis at the time of index admission. Figure 2 depicts comparisons of the 5 most common primary diagnoses at the time of index A total of 155 297 index admissions were found with a total of 619 720 total readmissions. After excluding readmissions that took place greater than 1 y after the index admission, this left 112 113 readmissions that were then linked to their corresponding index admissions. The index admission data were then excluded if patients failed to be categorized by the algorithm to identify adult congenital heart disease lesions, if a full 12-mo follow-up period before and after index admission was not available, if patients died during the index admission, if records were missing information required for analysis, and to remove outliers. This resulted in a final tally of 64 420 index admissions that were then used for analysis. admission among both patients who were and those who were not readmitted, divided by anatomic group. There were inadequate data available to perform this analysis on patients with anomalous pulmonary venous return.
Diagnosis at Readmission
Next, we investigated the most common primary diagnoses at the time of readmission among patients with ACHD who were readmitted within 12 months of an index hospitalization. CHF was the most common primary diagnosis at readmission for all ACHD and was among the 5 most common diagnoses at readmission in every diagnostic group. Cardiac dysrhythmia was the second most common overall diagnosis and was among the 5 most common diagnoses at readmission in every anatomic group except AV septal defect. Cardiac and circulatory congenital anomalies was the third most common overall readmission diagnosis and was among the 5 most common diagnoses at readmission in all anatomic groups except transposition of the great arteries, anomalous coronary artery, and among patients who failed to be categorized by the algorithm. We found significant lesion-specific variability in the diagnosis at the time of readmission. Figure 3 depicts the 5 most common diagnoses at readmission in each anatomic group. There were inadequate data available to perform this analysis in patients with anomalous pulmonary venous return. 
Predictors of Readmission
We next investigated risk factors for readmission based on multivariate regression models. Among all ACHD patients, we found that the 2 strongest predictors of readmission were chronic kidney disease (OR, 1.582; 95% CI, 1.4-1.7; P<0.0001), and diabetes mellitus with complications (OR, 1.523; 95% CI, 1.4-1.6; P<0.0001). We also found that having private insurance and having an index admission for complications of a medical or surgical procedure were the 2 strongest predictors of a decreased probability of readmission (OR, 0.59; 95% CI, 0.6-0.6; P<0.0001 and OR, 0.75; 95% CI, 0.7-0.8; P<0.0001, respectively). The 7 variables having the greatest effect on probability of readmission and which were statistically significant on multivariate analysis are listed in Table 2 .
Given the heterogeneity of ACHD, we next divided the study population into anatomic groups using the algorithm described by Broberg et al 13 and performed a similar analysis. Up to 7 variables in each anatomic subgroup having the greatest effect on probability of readmission and which were statistically significant on multivariate analysis are listed in Table 2 .
Discussion
The present study is an essential next step in deriving strategies to improve the quality of care for patients with ACHD. We recently investigated the annual cost of inpatient care for patients with ACHD and found that readmission was associated with the majority of variability in inpatient care cost. In the present study, we found that patients with ACHD were readmitted at high rates with >39% of patients readmitted within 12 months, most commonly for CHF and cardiac dysrhythmia. Furthermore, patients admitted with CHF once were more likely to be readmitted within 12 months than patients admitted with other diagnoses, indicating that these groups of patients are high-yield targets for intervention. We identified lesion-specific risk factors for readmission and found that these are dependent on cardiac anatomy, suggesting that it will require individualized lesion-specific strategies to improve care quality in ACHD.
The rate of rehospitalization in the ACHD population compared with control or other at-risk populations is difficult to assess based on the current analysis. We selected a 12-month follow-up for the present study because we recently demonstrated that rehospitalization within 12 months was a major driver of increased inpatient care cost in ACHD. Given that one of our primary goals in the present analysis was to identify hypotheses to direct strategies aimed at improving healthcare efficiency, the 12-month time point was therefore logical. It is almost certain that the readmission rate in ACHD is lower than that in CHF among patients with normal cardiac anatomy, where readmission rate among Medicare beneficiaries has been documented to be 44% at 6 months. 14 Nevertheless, direct comparison is difficult given differences in average age and comorbidities between the 2 groups. We found a higher rate of rehospitalization than that suggested in a recent cohort from Quebec and the Netherlands, which documented rates of hospitalization among patients with ACHD who had been previously hospitalized at ≈0.3 per patient-year. 15 This analysis was not focused on readmissions, however, making explanation of the reasons underlying the higher rates in the present cohort difficult. The observed difference may simply be related to any of a number of factors leading to the well documented increased rates of rehospitalization in the United States when compared with Canada and European countries. 16 The relative rates of rehospitalization for particular diagnoses are as expected and suggest the promise of diseasespecific management to improve health outcomes in ACHD. Subjects with simple lesions for which proven and effective treatment strategies exist such as aortic valve stenosis, PS and shunts had lower likelihoods of readmission than those with complex lesions such as Eisenmengers syndrome or single ventricle for which no therapy reliably alters disease progression. In the absence of good data to direct management, patients with these latter lesions would be expected to have an elevated probability of hospitalization, in particular after the advent of disease-related sequelae such as arrhythmia or CHF. In this regard, the present data may be useful in identifying those patients with more complex disease at elevated risk of readmission as targets for enrollment in clinical trials with the goal of modifying the natural history of the disease or of identifying thresholds for advanced therapy referral such as transplant.
The fact that the majority of rehospitalizations were attributable to either CHF or cardiac arrhythmia is not surprising. Previous studies have documented CHF and atrial arrhythmia to be common reasons for hospitalization in general and unplanned hospitalization specifically in patients with ACHD. 7, 17, 18 It is also not surprising that hospitalization once for either of these diagnoses was associated with a risk for rehospitalization. Readmission rates are known to be high among patients with a diagnosis of either CHF or atrial fibrillation in the general adult population although this has not previously been demonstrated to be the case in patients with ACHD in particular. 14, [19] [20] [21] [22] These data suggest that strategies proven to improve outcomes in CHF and atrial fibrillation may provide a reasonable framework on which to build care paradigms to decrease readmissions in ACHD. In deriving these paradigms, disease-specific interventions will need to be implemented in recognition of the fact that standard therapy for CHF has not yet been found to be beneficial in ACHD and that the most common arrhythmia for certain ACHD lesions is not atrial fibrillation.
Given the great heterogeneity of ACHD, identification and implementation of strategies to decrease rates of readmission will be complex. Based on the present data, we would propose the following approach as a starting point for this process: given the high incidence of hospitalization for CHF, and data indicating that patient education, careful care coordination, and early follow-up may decrease rates of rehospitalization in the general CHF population, we should attempt to reproduce these results using similar strategies in the ACHD population. [23] [24] [25] [26] The goals of predischarge and early postdischarge Not readmitted: number of patients in the indicated group with the indicated risk factor who were not readmitted. Readmitted: number of patients in the indicated group with the indicated risk factor who were readmitted. Rank indicates the relative importance of the identified variable in predicting risk of readmission for patients with the indicated congenital diagnosis based on regression analysis. Only variables found to have a statistically significant effect are reported. In certain cases, variables with large effects on regression failed to achieve statistical significance, because of low prevalence. As there was uncertainty about the validity of these effects, these variables were not reported and their ranks were bypassed. The 7 factors having the greatest effect on overall model variability are reported. AS indicates aortic valve stenosis; AVSD, AV septal defect; BAV, bicuspid aortic valve; CAD, coronary artery disease; CI, confidence interval; CHF, congestive heart failure; CKD, chronic kidney disease; CoA, coarctation of the aorta; CVD, cerebrovascular disease; DM, diabetes mellitus; HTN, hypertension; PS, congenital pulmonary stenosis; TGA, transposition of the great arteries; and VTE, venous thromboembolism.
*Comparisons for which there were fewer than 11 observations in one of the two comparator groups. 
Limitations
There are multiple limitations to the present study related to the use of administrative data. The completeness and accuracy of the data are dependent on the care with which data were entered, which is variable from institution to institution. In particular, the frequency with which the admitting diagnosis was cardiac and circulatory congenital anomaly is frustrating and uninformative, likely indicating that the coder used an International Classification of Diseases-Ninth Revision code for the patient's primary cardiac lesion when the patient was admitted for a cardiac reason related to that primary lesion. This finding highlights the limitations imposed on the utility of administrative data by suboptimal coding. Differentiation between differing congenital cardiac lesions is difficult given institutional variability in coding for similar lesions. Although we made every effort to include all patients with ACHD, to exclude patients without ACHD from analysis, and to correctly characterize patients based on underlying anatomy, no algorithm is foolproof, and it is almost certain that some patients in the present study were mischaracterized. In addition, given that the International Classification of Diseases-Ninth Revision does not distinguish between patent foramen ovale and atrial septal defect, some proportion of the present population classified as having shunt lesions may in fact have a patent foramen ovale. One of the unique components of the present study was the exclusive use of SIDs that permitted tracking of individual patients to detect rates of readmission. Tracking of individual patients, however, does not cross state lines. Even within states, the same patient admitted at different hospitals may have failed to be recognized as the same because of faulty data entry. In addition, SIDs do not fully track deaths, and it is possible that some patients succumbed before a full 12-month follow-up after an index hospitalization. Thus, the rehospitalization rate reported in the present study may be an underestimate.
Conclusions
Patients with ACHD have high readmission rates, predominantly for CHF and arrhythmia. Predictors of readmission are lesion specific, and future strategies aimed at decreasing readmission rate will likely need to be individualized. Initial trials aimed at reducing readmissions in ACHD might optimally target patients admitted with CHF and build on the paradigms found to be successful in decreasing readmissions in CHF.
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